First 3 runs free, then $50/run
    First 3 runs free, then $50/run

    Impact ledger

    Alkermes plc (ALKS): the developments shaping its investment case

    Follow the evidence affecting Alkermes plc. Review the key developments below. Continue in Market Ontology to test your assumptions, examine related opportunities, and save the investment case you want to track.

    Research Alkermes plc · $399/mo

    Test assumptions, examine opportunities, and save your research.

    Material developments

    2026-09-21
    Alkermes Announces Positive Phase 1b Results for ALKS 7290 in Adults With ADHD
    Channel: Direct positive clinical trial results for a pipeline asset, reducing R&D risk and increasing future revenue potential.
    Bullish· 1-3m
    2026-08-12
    Alkermes plc. Announces Refinancing of Tranche B Term Loans and Repricing of Tranche A Term Loans
    Channel: Direct impact on cost of debt and financial flexibility.
    Bullish· 1-3m
    2026-09-16 · 2 reports
    Alkermes plc Appoints Anne C. Whitaker to Board of Directors
    Channel: Improved corporate governance, strategic guidance, and potential for enhanced shareholder value through experienced leadership.
    Bullish· 3-12m

    Evidence affecting valuation assumptions

    Each entry names the assumption the evidence touches and how the evidence reads. Direction describes the business mechanism, not a stock-price conclusion.

    DateAssumptionDirectionInterpretation
    2026-07-08net_debtBearishLiability-management transactions often reduce gross debt or push maturities out.
    2026-07-08interest_expenseBearishTender/exchange extends maturity profile and typically lowers near-term interest expense.

    Event impact log

    4 events mapped to ALKS since 2026-08-12. Evidence through 2026-09-21.

    DateEventChannelDirectionHorizonImpact
    2026-09-21Alkermes Announces Positive Phase 1b Results for ALKS 7290 in Adults With ADHDDirect positive clinical trial results for a pipeline asset, reducing R&D risk and increasing future revenue potential.Bullish1-3m0.80
    2026-09-16Alkermes plc Appoints Anne C. Whitaker to Board of DirectorsImproved corporate governance, strategic guidance, and potential for enhanced shareholder value through experienced leadership.Bullish3-12m0.20
    2026-09-16Alkermes Announces Appointment of Anne C. Whitaker to Board of DirectorsGovernance improvement, strategic oversight, potential for enhanced decision-making and risk management.watch3-12m0.10
    2026-08-12Alkermes plc. Announces Refinancing of Tranche B Term Loans and Repricing of Tranche A Term LoansDirect impact on cost of debt and financial flexibility.Bullish1-3m0.70

    Continue this research

    Build your Alkermes plc investment case. Continue from the evidence above, change the assumptions the developments move, and save the work to revisit as the case develops.

    This ledger is regenerated from Market Ontology's public event pipeline. View the ALKS entity page →

    Research Alkermes plc · $399/mo